Silvia Guionaud

Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis

Michelle L. Boland, Rhianna C. Laker, KARLY M. MATHER et al. · Nature Metabolism · 2020 · 241 citations · Full text

Inflammation, Metabolic Syndrome, Fibrosis +15

Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice

Hani Jouihan, Sarah Will, Silvia Guionaud et al. · Molecular Metabolism · 2017 · 58 citations · Full text

Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction

Michelle L. Boland, Stephanie Oldham, Brandon B. Boland et al. · World Journal of Gastroenterology · 2018 · 50 citations · Full text

Nonclinical Safety Biomarkers of Drug-induced Vascular Injury

Igor Mikaelian, Mark J. Cameron, Deidre A. Dalmas et al. · Toxicologic Pathology · 2014 · 46 citations

Immunology, Cardiovascular Toxicity, Inflammation +17

Congenital hypotrichosis with anodontia in cattle: A genetic, clinical and histological analysis

Cord Drögemüller, Heidi Kuiper, Martin C. Peters et al. · Veterinary Dermatology · 2002 · 33 citations